The last few years have been rough for proponents of physician-owned distributorships (PODs), and a recent report from the Medicare Payment Advisory Commission is sure to complicate things further. PODs make money by selling devices that are then used in procedures performed by the physician-owners in hospital, and the report called for limiting the number of PODs and improving their Open Payments reporting.
The report falls in line with a growing consensus among legislators and regulators that PODs are “inherently suspect” and need to be closely monitored, Katie Pawlitz, a health-care attorney with Reed Smith LLP in Washington, told me.
A 2016 report from the Senate Finance Committee said PODs increase the risk of unnecessary surgeries and patient harm, as well pose a conflict of interest for physicians. A 2015 report from the Health and Human Services Office of Inspector General also said POD arrangement could raise the risks for Stark and anti-kickback violations.
Pawlitz said the MedPAC report acknowledges what the health-care industry has recognized as a loophole for POD Open Payment reporting. Certain PODs, such as those only sell to one entity, don’t have to report any payments to the Open Payments database since they don’t meet the definition of a group purchasing organization, Pawlitz said.
Pawlitz also said that PODs that are required to report may not be doing so. The Open Payments program, created under the Affordable Care Act, requires manufacturers of drugs, devices, and other medical supplies, along with group purchasing organizations, to report certain payments made to physicians and teaching hospitals.
The MedPAC report may lead to legislative or regulatory changes requiring all PODs to report Open Payments data, which would result in more information for consumers regarding industry relationships, Pawlitz said. If the changes don’t happen, the report may still encourage the Centers for Medicare & Medicaid Services to take a closer look at PODs that are currently required to report but aren’t doing so, Pawlitz said.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)